Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Familial risk of atrioventricular block in first-degree relatives

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sex differences in sudden cardiac death in a nationwide study of 54 028 deaths

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeartVR trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Dentist's visits and risk of brain abscess: a nationwide, population-based case control study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To assess the prevalence and severity of anaemia in patients with left-sided infective endocarditis (IE) and association with mortality.

METHODS: In the Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis trial, 400 patients with IE were randomised to conventional or partial oral antibiotic treatment after stabilisation of infection, showing non-inferiority. Haemoglobin (Hgb) levels were measured at randomisation. Primary outcomes were all-cause mortality after 6 months and 3 years. Patients who underwent valve surgery were excluded due to competing reasons for anaemia.

RESULTS: Out of 400 patients with IE, 248 (mean age 70.6 years (SD 11.1), 62 women (25.0%)) were medically managed; 37 (14.9%) patients had no anaemia, 139 (56.1%) had mild anaemia (Hgb <8.1 mmol/L in men and Hgb <7.5 mmol/L in women and Hgb ≥6.2 mmol/L) and 72 (29.0%) had moderate to severe anaemia (Hgb <6.2 mmol/L). Mortality rates in patients with no anaemia, mild anaemia and moderate to severe anaemia were 2.7%, 3.6% and 15.3% at 6-month follow-up and 13.5%, 20.1% and 34.7% at 3-year follow-up, respectively. Moderate to severe anaemia was associated with higher mortality after 6 months (HR 4.81, 95% CI 1.78 to 13.0, p=0.002) and after 3 years (HR 2.14, 95% CI 1.27 to 3.60, p=0.004) and remained significant after multivariable adjustment.

CONCLUSION: Moderate to severe anaemia was present in 29% of patients with medically treated IE after stabilisation of infection and was independently associated with higher mortality within the following 3 years. Further investigations are warranted to determine whether intensified treatment of anaemia in patients with IE might improve outcome.

Original languageEnglish
JournalHeart (British Cardiac Society)
Volume108
Issue number11
Pages (from-to)882-888
Number of pages7
ISSN1355-6037
DOIs
Publication statusPublished - 12 May 2022

Bibliographical note

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 68085784